Bristol Myers, 2seventy Get FDA OK for Earlier Abecma Use in Multiple Myeloma
Bristol Myers, 2seventy Get FDA OK for Earlier Abecma Use in Multiple Myeloma
Bristol Myers，270ty FDA 批准早些時候在多發性骨髓瘤中使用 Abecma
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊